Anti-inflammatory Peptides Market Report

China Anti-inflammatory Peptides Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：185
  • REPORT CODE：GMM1823075
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Anti-inflammatory Peptides industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Mylan Pharmaceuticals

    • Merck Serono

    • Araim Pharmaceuticals, Inc

    • Rogne Bioscience

    • F4 Pharma

    • Abbvie Corporation

    • Digna Biotech

    By Type:

    • Respiratory Diseases & Pulmonary

    • Cardiovascular Diseases

    • Dermatological Diseases

    • Transplantation

    • Otorhino Diseases & Ophthalmological

    • Neurological Diseases

    • Renal Diseases

    • Gastrointestinal Diseases

    • Rheumatological & Autoimmune Diseases

    By Application:

    • Household

    • Other

    • Clinic Use

    • Hospital Use

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Anti-inflammatory Peptides Market Overview 2018-2029

    • 1.1 China Anti-inflammatory Peptides Industry Development Overview

    • 1.2 China Anti-inflammatory Peptides Industry Development History

    • 1.3 China Anti-inflammatory Peptides Industry Market Size (2018-2029)

    • 1.4 China Anti-inflammatory Peptides Market Analysis by Type from Production Side

      • 1.4.1 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Respiratory Diseases & Pulmonary (2018-2029)

      • 1.4.2 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Cardiovascular Diseases (2018-2029)

      • 1.4.3 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Dermatological Diseases (2018-2029)

      • 1.4.4 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Transplantation (2018-2029)

      • 1.4.5 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Otorhino Diseases & Ophthalmological (2018-2029)

      • 1.4.6 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Neurological Diseases (2018-2029)

      • 1.4.7 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Renal Diseases (2018-2029)

      • 1.4.8 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Gastrointestinal Diseases (2018-2029)

      • 1.4.9 China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Rheumatological & Autoimmune Diseases (2018-2029)

    • 1.5 China Anti-inflammatory Peptides Market Analysis by Application from Consumption End

      • 1.5.1 China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Household (2018-2029)

      • 1.5.2 China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Clinic Use (2018-2029)

      • 1.5.4 China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Hospital Use (2018-2029)

    • 1.6 China Anti-inflammatory Peptides Market Analysis by Region

      • 1.6.1 North China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    Chapter 2 China Anti-inflammatory Peptides Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Anti-inflammatory Peptides Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Anti-inflammatory Peptides Market Status and Competition Analysis in 2023

      • 2.2.3 China Anti-inflammatory Peptides Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Anti-inflammatory Peptides Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Anti-inflammatory Peptides Industry Development

    Chapter 3 Anti-inflammatory PeptidesIndustry Chain Analysis

    • 3.1 Anti-inflammatory Peptides Industry Chain

    • 3.2 Anti-inflammatory Peptides Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Anti-inflammatory Peptides Market

    • 3.3 Anti-inflammatory Peptides Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Anti-inflammatory Peptides Market

    Chapter 4 China Anti-inflammatory Peptides Market, by Type

    • 4.1 China Anti-inflammatory Peptides Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Anti-inflammatory Peptides Total Production Volume and Growth Rate from Production Side

    • 4.5 China Anti-inflammatory Peptides Production Volume and Growth Rate, by Type

      • 4.5.1 China Anti-inflammatory Peptides Production Volume and Growth Rate of Respiratory Diseases & Pulmonary

      • 4.5.2 China Anti-inflammatory Peptides Production Volume and Growth Rate of Cardiovascular Diseases

      • 4.5.3 China Anti-inflammatory Peptides Production Volume and Growth Rate of Dermatological Diseases

      • 4.5.4 China Anti-inflammatory Peptides Production Volume and Growth Rate of Transplantation

      • 4.5.5 China Anti-inflammatory Peptides Production Volume and Growth Rate of Otorhino Diseases & Ophthalmological

      • 4.5.6 China Anti-inflammatory Peptides Production Volume and Growth Rate of Neurological Diseases

      • 4.5.7 China Anti-inflammatory Peptides Production Volume and Growth Rate of Renal Diseases

      • 4.5.8 China Anti-inflammatory Peptides Production Volume and Growth Rate of Gastrointestinal Diseases

      • 4.5.9 China Anti-inflammatory Peptides Production Volume and Growth Rate of Rheumatological & Autoimmune Diseases

    Chapter 5 China Anti-inflammatory Peptides Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Anti-inflammatory Peptides Total Market Size and Growth Rate from Consumption End

    • 5.5 China Anti-inflammatory Peptides Market Size and Growth Rate, by Application

      • 5.5.1 China Anti-inflammatory Peptides Market Size and Growth Rate of Household

      • 5.5.2 China Anti-inflammatory Peptides Market Size and Growth Rate of Other

      • 5.5.3 China Anti-inflammatory Peptides Market Size and Growth Rate of Clinic Use

      • 5.5.4 China Anti-inflammatory Peptides Market Size and Growth Rate of Hospital Use

    Chapter 6 China Anti-inflammatory Peptides Market, by Region

    • 6.1 China Anti-inflammatory Peptides Production Volume and Production Value, by Region

    • 6.2 China Anti-inflammatory Peptides Sales Volume and Sales Value, by Region

    Chapter 7 North China Anti-inflammatory Peptides Market Analysis

    • 7.1 North China Anti-inflammatory Peptides Market, by Type

    • 7.2 North China Anti-inflammatory Peptides Market, by Application

    Chapter 8 Central China Anti-inflammatory Peptides Market Analysis

    • 8.1 Central China Anti-inflammatory Peptides Market, by Type

    • 8.2 Central China Anti-inflammatory Peptides Market, by Application

    Chapter 9 South China Anti-inflammatory Peptides Market Analysis

    • 9.1 South China Anti-inflammatory Peptides Market, by Type

    • 9.2 South China Anti-inflammatory Peptides Market, by Application

    Chapter 10 East China Anti-inflammatory Peptides Market Analysis

    • 10.1 East China Anti-inflammatory Peptides Market, by Type

    • 10.2 East China Anti-inflammatory Peptides Market, by Application

    Chapter 11 Northeast China Anti-inflammatory Peptides Market Analysis

    • 11.1 Northeast China Anti-inflammatory Peptides Market, by Type

    • 11.2 Northeast China Anti-inflammatory Peptides Market, by Application

    Chapter 12 Southwest China Anti-inflammatory Peptides Market Analysis

    • 12.1 Southwest China Anti-inflammatory Peptides Market, by Type

    • 12.2 Southwest China Anti-inflammatory Peptides Market, by Application

    Chapter 13 Northwest China Anti-inflammatory Peptides Market Analysis

    • 13.1 Northwest China Anti-inflammatory Peptides Market, by Type

    • 13.2 Northwest China Anti-inflammatory Peptides Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Mylan Pharmaceuticals

        • 14.1.1 Mylan Pharmaceuticals Company Profile

        • 14.1.2 Mylan Pharmaceuticals Anti-inflammatory Peptides Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck Serono

        • 14.2.1 Merck Serono Company Profile

        • 14.2.2 Merck Serono Anti-inflammatory Peptides Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Araim Pharmaceuticals, Inc

        • 14.3.1 Araim Pharmaceuticals, Inc Company Profile

        • 14.3.2 Araim Pharmaceuticals, Inc Anti-inflammatory Peptides Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Rogne Bioscience

        • 14.4.1 Rogne Bioscience Company Profile

        • 14.4.2 Rogne Bioscience Anti-inflammatory Peptides Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 F4 Pharma

        • 14.5.1 F4 Pharma Company Profile

        • 14.5.2 F4 Pharma Anti-inflammatory Peptides Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Abbvie Corporation

        • 14.6.1 Abbvie Corporation Company Profile

        • 14.6.2 Abbvie Corporation Anti-inflammatory Peptides Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Digna Biotech

        • 14.7.1 Digna Biotech Company Profile

        • 14.7.2 Digna Biotech Anti-inflammatory Peptides Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Anti-inflammatory Peptides Industry Research Conclusions

    • 15.2 Anti-inflammatory Peptides Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Anti-inflammatory Peptides Industry Market Size (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Respiratory Diseases & Pulmonary (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Cardiovascular Diseases (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Dermatological Diseases (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Transplantation (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Otorhino Diseases & Ophthalmological (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Neurological Diseases (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Renal Diseases (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Gastrointestinal Diseases (2018-2029)

    • Figure China Anti-inflammatory Peptides Production Volume, Production Value and Growth Rate of Rheumatological & Autoimmune Diseases (2018-2029)

    • Figure China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Household (2018-2029)

    • Figure China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Clinic Use (2018-2029)

    • Figure China Anti-inflammatory Peptides Sales Volume, Sales Value and Growth Rate of Hospital Use (2018-2029)

    • Figure North China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure Central China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure South China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure East China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Anti-inflammatory Peptides Market Size and Growth Rate from 2018-2029

    • Figure Anti-inflammatory Peptides Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Anti-inflammatory Peptides Market Share by Type in 2018

    • Figure China Anti-inflammatory Peptides Market Share by Type in 2023

    • Figure China Anti-inflammatory Peptides Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Respiratory Diseases & Pulmonary (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Cardiovascular Diseases (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Dermatological Diseases (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Transplantation (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Otorhino Diseases & Ophthalmological (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Neurological Diseases (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Renal Diseases (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Gastrointestinal Diseases (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume and Growth Rate of Rheumatological & Autoimmune Diseases (2018-2023)

    • Figure China Anti-inflammatory Peptides Market Share by Application in 2018

    • Figure China Anti-inflammatory Peptides Market Share by Application in 2023

    • Figure China Anti-inflammatory Peptides Total Market Size and Growth Rate from Consumption End

    • Figure China Anti-inflammatory Peptides Market Size and Growth Rate of Household (2018-2023)

    • Figure China Anti-inflammatory Peptides Market Size and Growth Rate of Other (2018-2023)

    • Figure China Anti-inflammatory Peptides Market Size and Growth Rate of Clinic Use (2018-2023)

    • Figure China Anti-inflammatory Peptides Market Size and Growth Rate of Hospital Use (2018-2023)

    • Table China Anti-inflammatory Peptides Production Volume by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Production Volume Share by Region (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Volume Share by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Production Value by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Production Value Share by Region (2018-2023)

    • Figure China Anti-inflammatory Peptides Production Value Share by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Sales Volume by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Sales Volume Share by Region (2018-2023)

    • Figure China Anti-inflammatory Peptides Sales Volume Share by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Sales Value by Region (2018-2023)

    • Table China Anti-inflammatory Peptides Sales Value Share by Region (2018-2023)

    • Figure China Anti-inflammatory Peptides Sales Value Share by Region (2018-2023)

    • Table North China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table North China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure North China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table North China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table North China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure North China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table Central China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table Central China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure Central China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table Central China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table Central China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure Central China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table South China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table South China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure South China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table South China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table South China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure South China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table East China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table East China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure East China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table East China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table East China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure East China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table Northeast China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table Northeast China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure Northeast China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table Northeast China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table Northeast China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table Southwest China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table Southwest China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure Southwest China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table Southwest China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table Southwest China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table Northwest China Anti-inflammatory Peptides Production Volume by Type (2018-2023)

    • Table Northwest China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Figure Northwest China Anti-inflammatory Peptides Production Volume Share by Type (2018-2023)

    • Table Northwest China Anti-inflammatory Peptides Sales Volume by Application (2018-2023)

    • Table Northwest China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Anti-inflammatory Peptides Sales Volume Share by Application (2018-2023)

    • Table Mylan Pharmaceuticals Company Profile

    • Table Mylan Pharmaceuticals Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)

    • Table Merck Serono Company Profile

    • Table Merck Serono Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)

    • Table Araim Pharmaceuticals, Inc Company Profile

    • Table Araim Pharmaceuticals, Inc Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)

    • Table Rogne Bioscience Company Profile

    • Table Rogne Bioscience Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)

    • Table F4 Pharma Company Profile

    • Table F4 Pharma Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)

    • Table Abbvie Corporation Company Profile

    • Table Abbvie Corporation Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)

    • Table Digna Biotech Company Profile

    • Table Digna Biotech Anti-inflammatory Peptides Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US